Marion Leboyer – Institut Mondor, Créteil, France
Is it time for immunopsychiatry?
Major psychiatric disorders such as schizophrenia, bipolar disorder, depression, autism are frequent (affecting 30% of population in Europe). These disorders are thecauses behind chronic pathologies which are debilitating for sufferers in addition to being an economic burden for society. This is major public health issue, and it is set to become the number onecause of disability around the world by 2020. Yet these disorders are still not well understood and often diagnosed late reflecting a lack of understanding of the etiological mechanisms at work and the absence of therapeutical innovations in this domain. However, paradigm shifts and new etio-pathogenic hypotheses should quickly help us to develop new diagnostic and therapeutical tools. Hypotheses around immuno- inflammatory dysfunctions offer a new understanding of physio-pathological pathways which could explain
the complexity of these pathologies by placing them at the center of interactions between triggering and inducing factors that occur throughout a person’s life. They also offer the possibility of new diagnostics and therapeutic approaches, paving the way for personalized care that is in line with other fields of medicine. I will explain how these different approaches all offer tools with which we can better understand, diagnose and treat mental illness.
Neuroscience Seminar Series:
Friday, December 2nd, 2016 at 11:30 am, Salle des Conférences (R229), Centre Universitaire des Saints-Pères, 45 rue des Saints-Pères, 75006 Paris